With such precise and effective control of glutamate concentrations by two-photon photolysis of nitroindolinyl cages, we sought to develop a caged GABA (γ-aminobutyric acid) that could be photolyzed independently, at a longer, complementary wavelength of light. To achieve this goal, we used the 7-aminocoumarin chromophore 6-8 , which has a relative minimum at 280-330 nm and red-shifted absorption spectrum with respect to 4-carboxymethoxy-5,7-dinitroindolinyl-glutamate (CDNI-Glu) 9 (Fig. 1a,b) . We synthesized a 7-(dicarboxymethyl)-aminocoumarin-caged GABA, named N-DCAC-GABA (Fig. 1c and Online Methods). Release of caged amines from carbamates has a long half-time of about 4 ms 10 , but such compounds have the advantage of being very stable at physiological pH and are uncaged with usable efficiency 8 . A solution of N-DCAC-GABA at pH 7.4 was stable at room temperature (23-25 °C) for 2 months, was uncaged with a quantum yield of about 5% and released a product that activated a picrotoxinsensitive current ( Supplementary Fig. 1 ).
With such precise and effective control of glutamate concentrations by two-photon photolysis of nitroindolinyl cages, we sought to develop a caged GABA (γ-aminobutyric acid) that could be photolyzed independently, at a longer, complementary wavelength of light. To achieve this goal, we used the 7-aminocoumarin chromophore [6] [7] [8] , which has a relative minimum at 280-330 nm and red-shifted absorption spectrum with respect to 4-carboxymethoxy-5,7-dinitroindolinyl-glutamate (CDNI-Glu) 9 (Fig. 1a,b) . We synthesized a 7-(dicarboxymethyl)-aminocoumarin-caged GABA, named N-DCAC-GABA ( Fig. 1c and Online Methods). Release of caged amines from carbamates has a long half-time of about 4 ms 10 , but such compounds have the advantage of being very stable at physiological pH and are uncaged with usable efficiency 8 . A solution of N-DCAC-GABA at pH 7.4 was stable at room temperature (23-25 °C) for 2 months, was uncaged with a quantum yield of about 5% and released a product that activated a picrotoxinsensitive current (Supplementary Fig. 1 ).
We found that CDNI-Glu was uncaged 38 times more effectively at 720 nm than at 830 nm (the relative two-photon action cross-section, Y 1 , was 0.026; Fig. 1d ). In contrast, N-DCAC-GABA absorbed relatively more light at 830 nm (specifically, Y 2 = 0.3; Fig. 1e ). Thus, we applied both 2 mM CDNI-Glu and 4 mM N-DCAC-GABA from a puffer pipette to rat hippocampal brain slices ( Fig. 2a ; local application conserved caged compounds and diluted the probe concentration by approximately half at the target) and photolyzed each at powers that allowed independent, optically selective uncaging of glutamate and GABA (Fig. 2b-e) . For example, at pixel 1 in the image shown in Figure 2a , we detected a two-photon-evoked AMPA-R current (2pEPSC) at 720 nm (Fig. 2f) and a two-photon-evoked GABA-A receptor current (2pIPSC) at 830 nm (Fig. 2g) . Neither wavelength of light photolyzed the other caged compound to any great extent (Fig. 2c,d ). At pixel 2 in the image in Figure 2a We developed a caged Gaba (-aminobutyric acid), which, when combined with an appropriate caged glutamate, allows bimodal control of neuronal membrane potential with subcellular resolution using optically independent two-photon uncaging of each neurotransmitter. We used two-color, twophoton uncaging to fire and block action potentials from rat hippocampal ca1 neurons in brain slices with 720-nm and 830-nm light, respectively. our method should be generalizable to other chemical messenger pairs.
Two-photon microscopy 1 has recently revolutionized the biological sciences 2 . In particular, two features are proving to be very useful when compared with normal excitation modalities, namely imaging fluorescence signals from deep within living tissue and localized photochemical release of caged compounds. The nonlinear nature of two-photon excitation provides both of these benefits. Effective two-photon uncaging is predicated upon several chemical properties of the photosensitive probe 3 . Nitroindolinyl-caged glutamates have been used in many laboratories for two-photon uncaging experiments 4, 5 , implying such cages can be used with nontoxic photon fluxes. These probes are photolyzed in the 710-730 nm range such that the response at a spine head to the uncaged glutamate appears as that evoked by single-vesicle secretion 4 . irradiation at 830 nm evoked GABA-A receptor currents, whereas 720 nm light did not (Fig. 2h,i) , implying true color separation of photo-evoked currents under the conditions used for this experiment. Irradiation at 720 nm did not evoke any AMPA receptor currents at this pixel, suggesting receptor segregation along this portion of the dendrite. For these experiments (Fig. 2 ) the slower uncaging 10 of N-DCAC-GABA worked to our advantage, as the kinetics allowed us to segregate responses at the two wavelengths temporally. We found that the selectivity ratio for uncaging (the ratio between the amplitudes of 2pEPSC or 2pIPSC at 720 nm and 830 nm) was less than the noise level, in line with our theory that predicted the cross-talk to be 0.086 (Y 1 /Y 2 , Supplementary Note). Such selectivity was possible because two-photon excitation of CDNI-Glu at 720 nm tended to evoke much larger currents at lower power than N-DCAC-GABA with the concentrations of caged compounds we selected, such that irradiation at 720 nm cleanly stimulated AMPA receptors but not GABA receptors. As Y 1 = 0.026, this allowed us to use higher power at 830 nm without effective uncaging of CDNI-Glu at this longer wavelength. Given Y 2 = 0.3, such power effectively uncaged N-DCAC-GABA at 830 nm.
The combination of CDNI-Glu and N-DCAC-GABA has particular advantages for these two-color, two-photon mapping experiments. Many caged glutamate compounds have been reported 2, 3 , but only one, 4-methoxy-7-nitroindolinyl-glutamate (MNI-Glu) 4 , has been widely used for two-photon uncaging on brain slices 5 . As a caged glutamate, CDNI-Glu can be used at much lower concentrations than the widely used MNI-Glu probe and still allow effective two-photon photolysis at subtoxic energy dosage 9 . For this reason we selected this probe for the current work. A small variety of caged GABAs have been reported over the past 14 years 8, [11] [12] [13] [14] . Most of these probes [11] [12] [13] absorb in the same wavelength region as CDNI, and thus cannot be used for two-color uncaging. However, some offer longer wavelength absorption. RuBi-GABA probably cannot be used for two-photon uncaging because it has been reported to be toxic at concentrations greater than 20 µM 14 . Having two negative charges, N-DCAC-GABA is freely soluble in physiological buffer up to concentrations of at least 50 mM, whereas the simpler BC204 cage 8 might not be soluble enough for application at concentrations required for effective two-photon uncaging.
The mapping experiments shown in Figure 2 can be performed by retuning a single uncaging laser between 720 nm and 830 nm, but even though modern titanium:sapphire lasers are computercontrolled, the period for this switch is too long for rapid twocolor photolysis. Therefore, we developed a microscope with three titanium:sapphire lasers, which had two beams (720 and 830 nm) that were combined before entering the uncaging scan head (Supplementary Fig. 2 ). Using acousto-optical modulators, these two channels could be switched in about 10 µs. The third laser was used for imaging at 900 nm. This microscope enabled virtually simultaneous, optically selective uncaging of CDNI-Glu and N-DCAC-GABA on a living brain slice such that action potentials could be fired and blocked with subcellular precision (Fig. 3) . Initially we subjected several points around the soma of a CA1 pyramidal cell (Fig. 3a) at a holding potential of −20 mV to two-photon uncaging at 830 nm to find a GABA receptor 'hot spot' (Fig. 3b; notably, we detected no AMPA receptor currents in this case). Once we located such a density in voltage clamp, we switched to current clamp mode to induce a 2pIPSP at 830 nm (Fig. 3c) and to trigger action potentials by uncaging at 12 dendritic locations at 720 nm (Fig. 3d,e) . Action potential firing was blocked by prior uncaging of N-DCAC-GABA with 830 nm irradiation and resumed when the 830 nm beam was extinguished (Fig. 3e) . Thus, proper uncaging power levels and concentrations of CDNI-Glu and N-DCAC-GABA enabled two-color, two-photon uncaging of glutamate and GABA on the same neuron, with single synapse precision, and to our knowledge this is the first example of multimodal optical control of neuronal membrane potential by activation of native AMPA and GABA receptors.
Two other optical methods used to control neuronal membrane potential have been developed 15 . One uses cis to trans isomerization of azobenzene chemical probes to block and unblock ion channels. The second uses light-activated channels called channelrhodopsin-2 and halorhodopsin to control membrane potential. The azobenzene approach can fire action potentials by illumination at 380 nm and extinguish the evoked current by illumination at 500 nm. The advantages of caged compounds and azobenzenes arise from their use of exogenous probes. These methods can be directed to activate native receptors and are complementary to the channelrhodopsin-based approach. Notably, caged compounds are highly two-photon-active, and because native receptors are often densely clustered, two-photon photolysis can be used for selective stimulation of single synapses in neuronal circuits. Thus, uncaging is still the most useful method to address classical neurophysiological problems of synaptic function including dendritic integration, 'AND'-'OR' gate systems, diversity of GABA input points and others.
Two-color, two-photon uncaging is a major addition to the optical toolbox that is available to biologists as it offers direct photocontrol of symbiotic chemical messengers with subcellular resolution deep within biological tissue. Because uncaging works with the widest possible range of signaling systems 2,3 , two-color, two-photon uncaging offers the possibility of uncaging pairs of chemical signaling partners other than the one we report here. methods Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemethods/.
